The oxidative state of LDL is the major determinant of anti/prooxidant effect of coffee on Cu2+ catalysed peroxidation

Open Biochemistry Journal

Volumn 5, Issue , 2011, Pages 1-8

  Carru, Ciriaco ^a   Pasciu, Valeria ^a   Sotgia, Salvatore ^a   Zinellu, Angelo ^a   Nicoli, Maria Cristina ^b   Deiana, Luca ^a   Tadolini, Bruna ^a   Sanna, Bastiano ^a   Masala, Bruno ^a   Pintus, Gianfranco ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Antioxidant; LDL lag time; LDL oxidation; Prooxidant; Roasted coffee

Indexed keywords

ALKADIENE; COPPER ION; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CATALYSIS; COFFEE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; LIPID METABOLISM; LIPID OXIDATION; LIPID PEROXIDATION; METAL METABOLISM; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY;

EID: 79955062080     PISSN: None     EISSN: 1874091X     Source Type: Journal    
DOI: 10.2174/1874091X01105010001     Document Type: Article

References (31)

1. Hoff, H.F.; Gaubatz, J.W. Isolation, purification, and characterization of a lipoprotein containing Apo B from the human aorta. Atherosclerosis, 1982, 42, 273-297.
2. Palinski, W.; Rosenfeld, M.E.; Yla-Herttuala, S.; Gurtner, G.C.; Socher, S.S.; Butler, S.W.; Parthasarathy, S.; Carew, T.E.; Steinberg, D.; Witztum, JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA, 1989, 86, 1372-1376.
3. Steinberg, D.; Parthasarathy, S.; Carew, T.E.; Khoo, J.; Witztum, J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med., 1989, 20, 915-924.
4. Inoue, T.; Uchida, T.; Kamishirado, H.; Takayanagi, K.; Hayashi, T.; Morooka, S. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J. Am. Coll. Cardiol., 2001, 37, 775-779.
5. Riemersma, R.A.; Wood, D.A.; Macintyre, C.C.; Elton, R.A.; Gey, K.F.; Oliver, M.F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet, 1991, 337, 1-5.
6. Gey, K.F.; Moser, U.K.; Jordan, P.; Stahelin, H.; Eichholzer, M.; Lüdin, E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr., 1993, 57, 787-797.
7. Clifton, P.M. Antioxidant vitamins and coronary heart disease risk. Curr. Opin. Lipidol., 1995, 6, 20-24.
8. Kritharides, L.; Stocker, R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis, 2002, 164, 211-219.
9. Stephens, N.G.; Parsons, A.; Schofield, P.M.; Kelly, F.; Cheeseman, K.; Mitchinson, M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet, 1996, 347, 781-786.
10. Rapola, J.M.; Virtamo, J.; Ripatti, S.; Huttunen, J.K.; Albanes, D.; Taylor, P.R.; Heinonen, O.P. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 1997, 349, 1715-1720.
11. Yusuf, S.; Dagenais, G.; Pogue, J.; Bosch, J.; Sleight, P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med., 2000, 342, 154-160.
12. Hasnain, B.; Mooradian, A. Recent trials of antioxidant therapy: What should we be telling our patients? Cleve. Clin. J. Med., 2004, 71, 327-334.
13. Ferns, G.; Lamb, D. What does the lipoprotein oxidation phenomenon mean? Biochem. Soc. Trans., 2004, 32, 160-163.
14. Virtamo, J.; Pietinen, P.; Huttunen, J.K.; Korhonen, P.; Malila, N.; Virtanen, M.J.; Albanes, D.; Taylor, P.R.; Albert, P.; ATBC Study Group. Incidence of cancer and mortality following alphatocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA, 2003, 290, 476-485.
15. Lonn, E.; Bosch, J.; Yusuf, S.; Sheridan, P.; Pogue, J.; Arnold, J.M.; Ross, C.; Arnold, A.; Sleight, P.; Probstfield, J.; Dagenais, G.R.; HOPE and HOPE-TOO Trial Investigators. Effects of longterm vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 2005, 293, 1338-1347.
16. Miller, E.R.; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R.A.; Appel, L.J.; Guallar, E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med., 2005, 142, 37-46.
17. Kontush, A.; Finckh, B.; Karten, B.; Kohlschutter, A.; Beisiegel, U. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. J. Lipid Res., 1996, 37, 1436-1448.
18. Thomas, S.R.; Neuzil, J.; Stocker, R. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 687-696.
19. Bowen, H.T.; Omaye, S.T. Oxidative changes associated with betacarotene and alpha-tocopherol enrichment of human low-density lipoproteins. J. Am. Coll. Nutr., 1998, 17, 171-179.
20. Bagnati, M.; Perugini, C.; Cau, C.; Bordone, R.; Albano, E.; Bellomo, G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem. J. 1999, 340, 143-152.
21. Albertini, R.; Abuja, P.M. Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein. Free Radic. Res., 1999, 30, 181-188.
22. Esterbauer, H.; Striegl, G.; Puhl, H.; Rotheneder, M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun., 1989, 6, 67-75.
23. Nicoli, M.C.; Anese, M.; Manzocco, L.; Lerici, C.R. Antioxidant properties of coffee brews in relation to the roasting degree. LWTFood Sci. Technol., 1997, 30, 292-297.
24. Himber, J.; Buhler, E.; Moll, D.; Moser, U.K. Low-densitylipoprotein for oxidation and metabolic studies - isolation from small volumes of plasma using a tabletop ultracentrifuge. Int. J. Vitam. Nutr. Res., 1995, 65, 137-142.
25. Steinberg, D.; Witztum, J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation, 2002, 105, 2107-2111.
26. Tadolini, B.; Cabrini, L.; Menna, C.; Pinna, G.G.; Hakim, G. Iron (III) stimulation of lipid hydroperoxide-dependent lipid peroxidation. Free Radic. Res., 1997, 27, 563-576.
27. Tang, L.; Zhang, Y.; Qian, Z.; Shen, X. The mechanism of Fe(2+)- initiated lipid peroxidation in liposomes: the dual function of ferrous ions, the roles of the pre-existing lipid peroxides and the lipid peroxyl radical. Biochem. J., 2000, 352 Pt 1, 27-36.
28. Wilcox, A.L.; Marnett, L.J. Polyunsaturated Fatty-Acid Alkoxyl Radicals Exist as Carbon-Centered Epoxyallylic Radicals - a Key Step in Hydroperoxide-Amplified Lipid-Peroxidation. Chem. Res. Toxicol., 1993, 6, 413-416.
29. Minotti, G.; Aust, S.D. Redox Cycling of Iron and Lipid- Peroxidation. Lipids, 1992, 27, 219-226.
30. Perugini, C.; Bagnati, M.; Cau, C.; Bordone, R.; Zoppis, E.; Paffoni, P.; Re, R.; Albano, E.; Bellomo, G. Distribution of lipidsoluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition of lipoproteins. Pharmacol. Res., 2000, 41, 55-65.
31. Visioli, F.; Bordone, R.; Perugini, C.; Bagnati, M.; Cau, C.; Bellomo, G. The kinetics of copper-induced LDL oxidation depend upon its lipid composition and antioxidant content. Biochem. Biophys. Res. Commun., 2000, 268, 818-822.